EC

EcoR1 Capital Portfolio holdings

AUM $1.69B
1-Year Est. Return 7.54%
This Quarter Est. Return
1 Year Est. Return
+7.54%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.68B
AUM Growth
-$820M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
61
New
Increased
Reduced
Closed

Top Buys

1
+$33.3M
2
+$26.6M
3
+$17.8M
4
BEAM icon
Beam Therapeutics
BEAM
+$10.3M
5
QURE icon
uniQure
QURE
+$6.24M

Top Sells

1
+$129M
2
+$56.4M
3
+$32.7M
4
NMRA icon
Neumora Therapeutics
NMRA
+$22M
5
CRGX
CARGO Therapeutics
CRGX
+$21.2M

Sector Composition

1 Healthcare 99.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
REPL icon
26
Replimune Group
REPL
$700M
$8.29M 0.49%
850,341
BCYC
27
Bicycle Therapeutics
BCYC
$477M
$7.73M 0.46%
910,000
DAWN icon
28
Day One Biopharmaceuticals
DAWN
$748M
$6.84M 0.41%
862,068
VERV
29
DELISTED
Verve Therapeutics
VERV
$5.71M 0.34%
1,250,000
ADAP
30
DELISTED
Adaptimmune Therapeutics
ADAP
$5.4M 0.32%
27,404,070
GLPG icon
31
Galapagos
GLPG
$2.01B
$3.89M 0.23%
155,006
WHWK
32
Whitehawk Therapeutics
WHWK
$107M
$3.71M 0.22%
2,082,000
+1,736,747
ATRA icon
33
Atara Biotherapeutics
ATRA
$86.3M
$3.4M 0.2%
573,183
+41,049
SLDB icon
34
Solid Biosciences
SLDB
$344M
$2.75M 0.16%
+744,450
KROS icon
35
Keros Therapeutics
KROS
$474M
$1.91M 0.11%
187,500
NUVB.WS icon
36
Nuvation Bio Inc Warrants
NUVB.WS
$40.8M
$1.7M 0.1%
963,333
RLAY icon
37
Relay Therapeutics
RLAY
$1.18B
$1.68M 0.1%
641,426
KLRS
38
Kalaris Therapeutics
KLRS
$88.1M
$1.62M 0.1%
201,718
+183,949
PRME icon
39
Prime Medicine
PRME
$767M
$1.39M 0.08%
700,000
MTSR
40
Metsera Inc
MTSR
$7.7B
$1.36M 0.08%
+50,000
TCRX icon
41
TScan Therapeutics
TCRX
$63.6M
$915K 0.05%
662,833
-4,337,167
SRZNW icon
42
Surrozen Inc Warrant
SRZNW
$56.5K
$777K 0.05%
66,665
ALGS icon
43
Aligos Therapeutics
ALGS
$50.1M
$731K 0.04%
88,569
-167,004
UPB
44
Upstream Bio Inc
UPB
$1.35B
$367K 0.02%
60,000
ARVN icon
45
Arvinas
ARVN
$700M
– –
-6,726,491
AVIR icon
46
Atea Pharmaceuticals
AVIR
$255M
– –
-3,341,653
CRGX
47
DELISTED
CARGO Therapeutics
CRGX
– –
-1,470,000
DSGN icon
48
Design Therapeutics
DSGN
$355M
– –
-426,683
DYN icon
49
Dyne Therapeutics
DYN
$3.06B
– –
-555,644
FATE icon
50
Fate Therapeutics
FATE
$137M
– –
-3,049,405
1
2
3